Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
He is member of a data monitoring and safety board for Inventiva
The precise escalation regimen for any future approved formulation may differ substantially from trial protocols
Originally developed as an anti-obesity therapeutic, it has a strong safety profile from Phase II clinical trials and was even granted GRAS (Generally Recognised as Safe) status by the FDA for use in food products making its Category 2 classification particularly puzzling
Circulation changes: Some people notice slower blood flow to hands and feet, leaving them feeling chilly
Frkjaer JB et al
US$ 26.54
US$ 29.10
US$ 21.91
